Content about ProPhase Labs

February 18, 2014

This year, ECRM celebrates 20 years of successfully pairing buyers and sellers across the consumer packaged goods industry.

This year, ECRM celebrates 20 years of successfully pairing buyers and sellers across the consumer packaged goods industry. As part of that celebration, and in correlation to the ECRM Cough-Cold, Analgesics and Allergy event, DSN editors thought it’d be a good idea to look back through the last 20 years of the cough-cold business at retail.

August 22, 2013

The National Advertising Review Board determined that certain claims made by Matrixx Initiatives for its Zicam Cold Remedy products would not reasonably be understood to mean that use of the products prevents colds.

NEW YORK — The National Advertising Review Board on Wednesday determined that certain claims made by Matrixx Initiatives for its Zicam Cold Remedy products would not reasonably be understood to mean that use of the products prevents colds.

ProPhase Labs initially challenged several advertising claims for Zicam before the National Advertising Division, an investigative unit of the advertising industry’s system of self-regulation. NAD recommended Matrixx discontinue certain claims, which the company agreed to do.

April 5, 2013

The National Advertising Division on Friday recommended that Matrixx Initiatives discontinue advertising claims that suggest its homeopathic Zicam Cold Remedy products prevent users from catching a cold.

NEW YORK — The National Advertising Division on Friday recommended that Matrixx Initiatives discontinue advertising claims that suggest its homeopathic Zicam Cold Remedy products prevent users from catching a cold.

Claims at issue were featured in an advertising campaign that depicted a “Cold Monster” and encouraged treatment with Zicam products at the “pre-cold” stage.

December 27, 2012

ProPhase Labs recently announced that its Cold-Eeze Cold Remedy will be sponsoring a New Jersey television personality to help raise money for Camp Sunshine, a retreat in Casco, Maine for kids with life threatening illnesses and their families.

CONEY ISLAND, N.Y. — ProPhase Labs recently announced that its Cold-Eeze Cold Remedy will sponsor a New Jersey television personality to help raise money for Camp Sunshine, a retreat in Casco, Maine for kids with life-threatening illnesses and their families. 

On Jan. 1, "Jersey Shore" star Vinny Guadagnino will take the plunge as part of the annual Coney Island Polar Bear Plunge New Year’s Day event. 

This is Vinny’s second year doing the Polar Bear Plunge, ProPhase noted.

December 13, 2012

Makers of Cold-EEZE, Prophase Labs, a leader in OTC natural cold remedies, has announced its support for the Daily News Readers' "Care to Feed the Hungry Canned Food Drive."

DOYLESTOWN, Pa. — Makers of Cold-EEZE, Prophase Labs, a leader in OTC natural cold remedies, has announced its support for the Daily News Readers' "Care to Feed the Hungry Canned Food Drive," a 30-year tradition of collecting nonperishable food donations throughout New York City.

October 29, 2012

ProPhase Labs on Monday again rejected an acquisition proposal from Matrixx Initiatives. Matrixx's latest offer was to acquire ProPhase for $1.60 per share in cash, up from a prior $1.40 per share proposal.

DOYLESTOWN, Pa. — ProPhase Labs on Monday again rejected an acquisition proposal from Matrixx Initiatives. Matrixx's latest offer was to acquire ProPhase for $1.60 per share in cash, up from a prior $1.40 per share proposal. 

October 9, 2012

Matrixx Initiatives on Tuesday announced its second overture to ProPhase Labs with an increased acquisition offer of $1.60 per share.

SKILLMAN, N.J. — Matrixx Initiatives on Tuesday announced its second overture to ProPhase Labs with an increased acquisition offer of $1.60 per share. The revised offer represents a premium of 51.7% over the 30-day average closing price of ProPhase's stock and a 53.7% premium to ProPhase's average closing price over the 12 months preceding Sept. 6 — the day ProPhase's former chairman and CEO, Guy Quigley, filed a Schedule 13D announcing Matrixx's purchase of a three-year option to acquire 1.45 million shares of ProPhase common stock.

September 17, 2012

ProPhase Labs on Monday announced that it rejected an unsolicited, nonbinding proposal from Matrixx Initiatives to acquire the company for $1.40 per share in cash, subject to further due diligence by Matrixx.

DOYLESTOWN, Pa. — ProPhase Labs on Monday announced that it rejected an unsolicited, nonbinding proposal from Matrixx Initiatives to acquire the company for $1.40 per share in cash, subject to further due diligence by Matrixx.

ProPhase stock was up 20 cents to $1.39 in mid-afternoon trading.

Matrixx is the owner of the Zicam brand of cold and allergy products and is a direct competitor to ProPhase's Cold-Eeze Cold Remedy product line.

July 2, 2012

ProPhase Labs has expanded its Cold-Eeze brand.

DOYLESTOWN, Pa. — ProPhase Labs has expanded its Cold-Eeze brand.

New Cold-Eeze cold remedy Daytime/Nighttime QuickMelt tablets are designed to shorten a cold, ProPhase Labs said. The Daytime QuickMelt tablets shorten one's cold and are nondrowsy, while the Nighttime QuickMelt tablets are a combination product formulated to shorten a cold and also help users fall asleep faster and contain natural, extra-strength chamomile and melatonin. Each package comes with 18 Daytime QuickMelt tablets and six Nighttime QuickMelt tablets.

May 11, 2012

The lackluster cough-cold season will necessitate a greater need for marketing and promotion next season, ProPhase Labs chairman and CEO Ted Karkus said on Thursday in announcing first-quarter results for the period ended March 31.

DOYLESTOWN, Pa. — The lackluster cough-cold season will necessitate a greater need for marketing and promotion next season, ProPhase Labs chairman and CEO Ted Karkus said on Thursday in announcing first-quarter results for the period ended March 31.

January 27, 2012

ProPhase Labs on Thursday named the October, November and December winners of its "Share Your Cause Not Your Cold" campaign.

DOYLESTOWN, Pa. — ProPhase Labs on Thursday named the October, November and December winners of its "Share Your Cause Not Your Cold" campaign. ProPhase awarded $1,000 to three charities: LuLu's Rescue, an all-volunteer, companion animal rescue group; Backpack Buddies, which provides weekend meals to students in need; and Hannah's Home, a respite for single, young women who are pregnant.

November 28, 2011

ProPhase Labs on Monday partnered with Give2TheTroops to aid in the combat against the common cold this holiday season.

DOYLESTOWN, Pa. — ProPhase Labs on Monday partnered with Give2TheTroops to aid in the combat against the common cold this holiday season. Men and women serving in the Persian Gulf, Afghanistan, Kosovo and other combat and disaster-relief zones are set to receive Cold-Eeze products in personalized care packages.

November 18, 2011

ProPhase Labs on Thursday announced that its Cold-Eeze product has been awarded the Parent Tested, Parent Approved Winner's Seal of Approval.

DOYLESTOWN, Pa. — ProPhase Labs on Thursday announced that its Cold-Eeze product has been awarded the Parent Tested, Parent Approved Winner's Seal of Approval. 

PTPA Media has North America's largest volunteer parent testing community, with more than 40,000 parents. The seal of approval is awarded based on quality, effectiveness and value.

November 1, 2011

ProPhase Labs on Tuesday launched the Cold-Eeze oral spray, which is formulated with zinc gluconate to help reduce the severity and duration of the common cold.

DOYLESTOWN, Pa. — ProPhase Labs on Tuesday launched the Cold-Eeze oral spray, which is formulated with zinc gluconate to help reduce the severity and duration of the common cold.

July 5, 2011

ProPhase Labs on Tuesday announced that it received a letter from the NASDAQ Stock Market indicating that the company no longer is in compliance with NASDAQ listing rules because the closing bid price per share of its common stock has dropped below $1 per share for 30 consecutive trading days.

DOYLESTOWN, Pa. — ProPhase Labs on Tuesday announced that it received a letter from the NASDAQ Stock Market indicating that the company no longer is in compliance with NASDAQ listing rules because the closing bid price per share of its common stock has dropped below $1 per share for 30 consecutive trading days.

ProPhase will have until Dec. 27 to push its stock price above $1 for a minimum of 10 consecutive trading days to regain compliance or risk being delisted.

March 4, 2011

DOYLESTOWN, Pa. — ProPhase Labs last month created a Facebook personality quiz to benefit the American Heart Association. For each Facebook fan who takes the “What’s Your Cold-Eeze Flavor?” personality quiz, ProPhase will donate $1 to the AHA, up to a total of $2,500.

January 14, 2011

ProPhase Labs on Thursday announced its title sponsor of the "Cold-Eeze Skate for the Heart" show, airing on NBC stations Jan. 16 from 4 to 6 p.m., EST.

DOYLESTOWN, Pa. — ProPhase Labs on Thursday announced its title sponsor of the "Cold-Eeze Skate for the Heart" show, airing on NBC stations Jan. 16 from 4 to 6 p.m., EST.

"We are so proud to support these world-class skaters and the critical heart health cause," stated Ted Karkus, CEO of ProPhase Labs. "We are also huge fans of the amazing singers in the show."

September 6, 2010

ProPhase Labs on Tuesday announced it has retained media solutions company Women's Marketing as its...

DOYLESTOWN, Pa. ProPhase Labs on Tuesday announced it has retained media solutions company Women's Marketing as its agency of record. The agency will work closely with ProPhase Labs to develop and implement high-impact media campaigns for Cold-Eeze and Kids-Eeze across a variety of networks, the company stated.

 

The ad campaigns coincide with improvements to Cold-Eeze and Kids-Eeze product and packaging, including a Kids-Eeze line of symptom relievers in a "chew" form.